NanoXplore Past Earnings Performance
Past criteria checks 0/6
NanoXplore's earnings have been declining at an average annual rate of -3.6%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 16.5% per year.
Key information
-3.6%
Earnings growth rate
4.7%
EPS growth rate
| Chemicals Industry Growth | 12.4% |
| Revenue growth rate | 16.5% |
| Return on equity | -10.1% |
| Net Margin | -7.9% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How NanoXplore makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 135 | -11 | 23 | 5 |
| 30 Jun 24 | 130 | -12 | 23 | 5 |
| 31 Mar 24 | 125 | -11 | 23 | 5 |
| 31 Dec 23 | 123 | -11 | 22 | 4 |
| 30 Sep 23 | 126 | -11 | 22 | 4 |
| 30 Jun 23 | 124 | -13 | 21 | 3 |
| 31 Mar 23 | 119 | -14 | 19 | 3 |
| 31 Dec 22 | 116 | -16 | 19 | 3 |
| 30 Sep 22 | 103 | -17 | 18 | 3 |
| 30 Jun 22 | 93 | -16 | 17 | 4 |
| 31 Mar 22 | 85 | -17 | 18 | 4 |
| 31 Dec 21 | 74 | -17 | 16 | 4 |
| 30 Sep 21 | 72 | -16 | 16 | 4 |
| 30 Jun 21 | 68 | -12 | 15 | 4 |
| 31 Mar 21 | 58 | -8 | 13 | 3 |
| 31 Dec 20 | 55 | -7 | 13 | 3 |
| 30 Sep 20 | 57 | -6 | 12 | 3 |
| 30 Jun 20 | 63 | -8 | 12 | 3 |
| 31 Mar 20 | 75 | -12 | 14 | 3 |
| 31 Dec 19 | 81 | -12 | 16 | 3 |
| 30 Sep 19 | 86 | -11 | 16 | 3 |
| 30 Jun 19 | 70 | -11 | 14 | 3 |
| 31 Mar 19 | 50 | -7 | 11 | 2 |
| 31 Dec 18 | 32 | -6 | 8 | 2 |
| 30 Sep 18 | 12 | -5 | 5 | 1 |
| 30 Jun 18 | 9 | -6 | 5 | 1 |
| 31 Mar 18 | 6 | -5 | 4 | 1 |
| 31 Dec 17 | 4 | -5 | 4 | 0 |
| 30 Sep 17 | 3 | -4 | 3 | 0 |
| 30 Jun 17 | 3 | -2 | 4 | 0 |
| 31 Mar 17 | 2 | -2 | 4 | 0 |
| 30 Jun 16 | 0 | -1 | 2 | 0 |
| 30 Jun 15 | 0 | -1 | 1 | 0 |
Quality Earnings: N13 is currently unprofitable.
Growing Profit Margin: N13 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: N13 is unprofitable, and losses have increased over the past 5 years at a rate of 3.6% per year.
Accelerating Growth: Unable to compare N13's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: N13 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (5%).
Return on Equity
High ROE: N13 has a negative Return on Equity (-10.1%), as it is currently unprofitable.